Molecular Biology Fall 2016
Wednesday, November 30, 2016
Hope for Alcohol Abuse
Alcoholism is a pretty serious topic. I’m sure we all know at least one person who suffers from alcoholism or alcohol dependence. For me, it’s my grandfather. He’s been a heavy drinker since I was a little kid. I don’t think I’ve ever seen the man sober. According to the National Council on Alcoholism and Drug Dependence, 17.6 people suffer from alcohol abuse or dependence. But what of there was a way to decrease the desire to drink?
Researcher have identified a gene that suppresses the desire to drink. In a study, researchers looked at 105,00 light and heavy drinkers and found that a variation of the β-Klotho gene was linked to how much alcohol was consumed by participants. The less common variant of the gene was associated with the desire to consume. Those who had this variant tended to consume less alcohol than those who didn’t have it. This gene is associated with alcohol consumption because it directs the production of the β-Klotho protein that forms part of a receptor in the brain.
It is possible that this research could lead to medications for alcoholism and alcohol dependence. While drugs to combat these issues would be great, I know my grandfather would never consider taking a medication. You can’t force someone to take a drug. People still have to want to get better. Do you think these medications would be effective in decreasing alcohol related issues?
Further Readings:
http://www.pnas.org/content/early/2016/11/22/1611243113
http://www.utsouthwestern.edu/newsroom/news-releases/year-2016/nov/social-drinking.html
Saturday, November 26, 2016
Astrovirus Vaccine
An astrovirus is a type of virus that just about everyone
gets when they’re a kid. It usually isn’t anything too serious. Just the typical
flu symptoms, vomiting, fever, etc. However, these viruses can be dangerous for
children undergoing chemotherapy because their immune systems are already degraded.
They can also infect the elderly and
others with weakened immune systems.
Researchers at The University of California Santa Cruz are
working on antiviral therapies and vaccines for these viruses. They used x-ray
crystallography to see how a specific protein structure on the surface of the
virus is blocked by an antibody. They were able to see how the antibody binds
to the astrovirus capsid spike domain. The antibody can stop the virus from attaching
to a human cell. This site of the virus can be targeted for developing antiviral
therapies and vaccines.
A vaccine or antiviral medicines for these viruses would be
a huge success. Not only could it help those already mentioned, it could also
help those suffering from autoimmune diseases and HIV. While I won’t be jumping
in line to get the vaccine, as I don’t think I really need it, I would definitely
want my aging grandmother to.
Further Readings:
http://jvi.asm.org/content/early/2016/10/27/JVI.01859-16
Wednesday, November 23, 2016
Zika Replicons
I’m sure that by now most of us are pretty familiar with the
Zika virus. Just in case you aren’t, I’ll give a little background. A person
becomes infected with the virus when an infected mosquito bites them. In most
cases, Zika isn’t that serious. Some may experience mild symptoms while others
don’t experience any at all. However, if a woman is pregnant when she becomes
infected, the virus can also infect the fetus causing serious birth defects. As
of right now, there is no vaccine for the virus.
BUT researchers are on their way to finding one. Researcher
from Texas, China, and Belgium are working together on a tool called a “replicon
system”. Replicons are bits of the viral genome that are able to replicate
without the machinery of a host cell. Replicons are used in drug development for
studying viruses. For this research, an experimental system was made that
creates replicons of the Zika virus that don’t have the genes that make the
virus infectious. Making this form of
the virus less dangerous to work with and study. The replicons can be used to
locate parts of the virus that block replication. Researcher are able to attach
genes to the replicons so they can tag parts of the virus they want to study. This
information can be used in vaccine development because it can show how the
virus is mutating and evolving.
While we still don’t have a vaccine for this virus right
now, we might be looking at one sooner than we would have thought.
Further Readings:
http://www.ebiomedicine.com/article/S2352-3964(16)30420-0/pdf
Subscribe to:
Posts (Atom)